Market Cap 3.76B 1B 861M 810M 739M 1.38B 94.68B 1.39B 9.6B 3.71B 48.49B 3.68B 154B P/E 2026 *
19.3x
P/E 2027 * 15.3x
Enterprise Value 4.77B 1.27B 1.09B 1.03B 938M 1.75B 120B 1.76B 12.19B 4.71B 61.54B 4.67B 196B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.42x
Free-Float
88.97%
Yield 2026 *
1.25%
Yield 2027 * 2.77%
1 day+1.48%
1 week+3.89%
Current month+3.89%
1 month+0.19%
3 months+10.92%
6 months+16.75%
Current year+20.87%
1 week 30
Extreme 30
31.86
1 month 30
Extreme 30
31.86
Current year 24.96
Extreme 24.96
33.12
1 year 24.96
Extreme 24.96
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
53.8
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 2021-01-04
Chief Executive Officer - 2025-04-06
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2016-04-02
Director/Board Member - 2019-04-02
Director/Board Member - 2019-04-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%+3.89%+14.63%-12.38% 1B
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.95%+0.23%+28.96%+37.78% 349B
-3.18%+1.78%+20.66%+41.55% 295B
+0.30%+0.60%-0.40%+11.25% 253B
-1.55%+1.71%+54.15%+71.87% 236B
+0.02%+2.24%-14.59%-55.80% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -0.75%+1.22%+26.76%+44.32% 366.83B
Weighted average by Cap. -1.06%+0.63%+37.23%+64.54%

Financials

2026 *2027 *
Net sales 1.8B 479M 412M 388M 354M 662M 45.32B 664M 4.6B 1.78B 23.21B 1.76B 73.93B 1.91B 510M 438M 412M 376M 704M 48.2B 706M 4.89B 1.89B 24.68B 1.87B 78.62B
Net income 195M 51.91M 44.65M 41.99M 38.33M 71.69M 4.91B 71.92M 498M 192M 2.51B 191M 8.01B 248M 66.16M 56.9M 53.51M 48.85M 91.36M 6.26B 91.66M 635M 245M 3.2B 243M 10.21B
Net Debt 1.01B 270M 232M 218M 199M 372M 25.49B 373M 2.59B 999M 13.06B 990M 41.58B 863M 230M 198M 186M 170M 317M 21.73B 318M 2.2B 852M 11.13B 844M 35.45B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
26-09-07 SAR 31.50 +1.48% 648,537
26-09-06 SAR 31.04 +0.78% 12,887,204
26-09-03 SAR 30.80 +0.13% 263,195
26-09-02 SAR 30.76 -0.58% 279,436
26-09-01 SAR 30.94 +2.04% 282,608
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
31.50SAR
Average target price
32.80SAR
Spread / Average Target
+4.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!